subscribeSubscribe
Seagen Eyes a Key Frontline Indication for Top-Seller Adcetris

Seagen Eyes a Key Frontline Indication for Top-Seller Adcetris
Kate Goodwin BIOSPACE
13 Dec 2022
Share Share
Teva`s troubled plant seen to create injectable drug shortages

Teva`s troubled plant seen to create injectable drug shortages
Joseph Keenan FIERCEPHARMA
24 May 2022
Share Share
ADCETRIS Combination Significantly Improves Overall Survival in Hodgkin Lymphoma

ADCETRIS Combination Significantly Improves Overall Survival in Hodgkin Lymphoma
BUSINESSWIRE
03 Feb 2022
Share Share
Seagen Announces Preliminary Results from Phase 2 Trial of ADCETRIS

Seagen Announces Preliminary Results from Phase 2 Trial of ADCETRIS
BUSINESSWIRE
12 Dec 2021
Share Share
Enforcement Report - Week of March 3, 2021

Enforcement Report - Week of March 3, 2021
FDA
03 Mar 2021
Share Share
European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD

European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD
BUSINESSWIRE
11 Feb 2019
Share Share
US FDA accepts sBLA & grants priority review status for Adcetris

US FDA accepts sBLA & grants priority review status for Adcetris
PHARMABIZ
04 Jan 2018
Share Share
Will subgroup stumbles for Adcetris hurt its sales potential?

Will subgroup stumbles for Adcetris hurt its sales potential?
Carly Helfand FIERCE PHARMA
12 Dec 2017
Share Share
FDA approves Eisai`s drug Halaven for type of soft tissue cancer

FDA approves Eisai`s drug Halaven for type of soft tissue cancer
FDA
28 Jan 2016
Share Share
Array`s skin cancer drug succeeds in late-stage study

Array`s skin cancer drug succeeds in late-stage study
Natalie Grover REUTERS
17 Dec 2015
Share Share